EUVIMEDEUVIMED entdecken
Crossref

Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients

Chloé Bianchi, Henri Margot, Helder Fernandes, Marlène Pasquet, Laurence Priqueler, Frédérique Roy-Peaud, Frédéric Bauduer, Sophie Bayart, Nathalie Garnier, Olivier Fain, Julien Van Gils, Sandrine Baron Joly und 13 weitere

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Chloé Bianchi und 24 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Haemato-Immunology, CIC1401, INSERM CICP, National Reference Center for Autoimmune Cytopenias in Children (CEREVANCE), Bordeaux University …. Hauptthemen laut MEDLINE: Vestibular Diseases, Face, Abnormalities, Multiple, Histone Demethylases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Association Française du Syndrome d'Evans (AFSE), the O-CYTO patients' association, Ministère de la Santé, Association pour la Recherche et les Maladies Hématologiques de l'Enfant (RMHE) research charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kabuki syndrome (KS) is now listed in the Human Inborn Errors of Immunity (IEI) Classification. It is a rare disease caused by KMT2D and KDM6A variants, dominated by intellectual disability and characteristic facial features. Recurrently, pathogenic variants are identified in those genes in patients examined for autoimmune cytopenia (AIC), but interpretation remains challenging. This study aims to describe the genetic diagnosis and the clinical management of patients with paediatric‐onset AIC and KS. Among 11 patients with AIC and KS, all had chronic immune thrombocytopenic purpura, and seven had Evans syndrome. All had other associated immunopathological manifestations, mainly symptomatic hypogammaglobinaemia. They had a median of 8 (5–10) KS‐associated manifestations. Pathogenic variants were detected in KMT2D gene without clustering, during the immunological work‐up of AIC in three cases, and the clinical strategy to validate them is emphasized. Eight patients received second‐line treatments, mainly rituximab and mycophenolate mofetil. With a median follow‐up of 17 (2–31) years, 8/10 alive patients still needed treatment for AIC. First‐line paediatricians should be able to recognize and confirm KS in children with ITP or multiple AIC, to provide early appropriate clinical management and specific long‐term follow‐up. The epigenetic immune dysregulation in KS opens exciting new perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vestibular DiseasesFaceAbnormalities, MultipleHistone DemethylasesNeoplasm ProteinsHematologic DiseasesDNA-Binding ProteinsHumansChildFemaleMaleChild, PreschoolAdolescentPurpura, Thrombocytopenic, IdiopathicInfantThrombocytopeniaAnemia, Hemolytic, AutoimmuneAutoimmune DiseasesRituximabMutationCytopenia

Stichwörter der Autor:innen

Evans syndromeKabuki syndromechildhood ITPimmune thrombocytopenic purpurainherited errors of immunity

Substanzen

KMT2D protein, humanKDM6A protein, humanHistone DemethylasesNeoplasm ProteinsDNA-Binding ProteinsRituximab

Autor:innen und Institutionen

  • Pediatric Haemato-Immunology, CIC1401, INSERM CICP, National Reference Center for Autoimmune Cytopenias in Children (CEREVANCE), Bordeaux University Hospital, Bordeaux, France.
  • Department of Medical Genetics, MRGM INSERM U1211, Bordeaux University Hospital, University of Bordeaux, Bordeaux, France.
  • Pediatric Oncology Immunology Hematology Unit, Children's University Hospital, Toulouse, France.
  • Department of Pediatrics, Mont de Marsan Hospital Center, Mont de Marsan, France.
  • Internal Medicine Department, Poitiers University Hospitals, Poitiers, France.
  • Hematology Department, Côte Basque Hospital, Bayonne, France.

ORCID-Profile: Sébastien Héritier, Nathalie Aladjidi

Förderung

  • Association Française du Syndrome d'Evans (AFSE), the O-CYTO patients' association
  • Ministère de la Santé
  • Association pour la Recherche et les Maladies Hématologiques de l'Enfant (RMHE) research charity

Zitieren

APA

Bianchi, C., Margot, H., Fernandes, H., Pasquet, M., Priqueler, L., Roy-Peaud, F., Bauduer, F., Bayart, S., Garnier, N., Fain, O., Van Gils, J., Joly, S. B., Rialland, F., Paillard, C., Deparis, M., Lambilliotte, A., Leblanc, T., Fahd, M., Leverger, G., …, & Aladjidi, N. (2024). Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients. British Journal of Haematology. https://doi.org/10.1111/bjh.19387

Vancouver

Bianchi C, Margot H, Fernandes H, Pasquet M, Priqueler L, Roy-Peaud F, et al. Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients. British Journal of Haematology. 2024. doi:10.1111/bjh.19387

BibTeX
@article{Bianchi2024,
  author = {Bianchi, Chloé and Margot, Henri and Fernandes, Helder and Pasquet, Marlène and Priqueler, Laurence and Roy-Peaud, Frédérique and Bauduer, Frédéric and Bayart, Sophie and Garnier, Nathalie and Fain, Olivier and Van Gils, Julien and Joly, Sandrine Baron and Rialland, Fanny and Paillard, Catherine and Deparis, Marianna and Lambilliotte, Anne and Leblanc, Thierry and Fahd, Mony and Leverger, Guy and Héritier, Sébastien and Geneviève, David and Rieux-Laucat, Frédéric and Picard, Capucine and Neyraud, Caroline and Aladjidi, Nathalie},
  title = {Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19387}
}
Kostenlos starten →